Identification of novel compound heterozygous variants in a pedigree affected with hereditary coagulation factor XI deficiency.
10.3760/cma.j.issn.1003-9406.2020.05.002
- Author:
Hong XIA
1
;
Xiaolong LI
;
Liqing ZHU
;
Yanhui JIN
;
Lihong YANG
;
Jingye PAN
;
Haiyue ZHANG
;
Mingshan WANG
Author Information
1. Center of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325015, China. wywms@126.com.
- Publication Type:Case Reports
- MeSH:
Factor XI Deficiency;
genetics;
Female;
Genetic Variation;
Heterozygote;
Humans;
Mutation;
Pedigree
- From:
Chinese Journal of Medical Genetics
2020;37(5):501-504
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the phenotype and genetic basis for a pedigree affected with hereditary coagulation factor XI deficiency.
METHODS:Activated partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen (FIB), FXI activity (FXI:C) and the antigen of FXI (FXI:Ag) were determined for the proband and members from his pedigree. Sanger sequencing was used to analyze all exons, exon-intronic boundaries, as well as the 5'- and 3'- untranslated regions of the F11 gene. Suspected variants were verified in her family members and confirmed by reverse sequencing. The impact of the variants on the protein function was predicted by using PolyPhen-2 and SIFT software. The protein structure and amino acid interaction were analyzed by using Swiss-PdbViewer.
RESULTS:The APTT, FXI:C and FXI:Ag of the proband and her sister were significantly reduced to 73.0 s, 10.0%, 15.0% and 87.1 s, 2.0% and 11.5%, respectively. APTT of some family members was slightly prolonged, and FXI:C and FXI:Ag also decreased to various extents. DNA sequencing revealed that the proband and her sister have carried compound heterozygous variants of c.738G>A (p.Trp228stop) and c.938G>T (p.Ser295Ile) respectively in exons 7 and 9 of the F11 gene. Her father, sister and daughter were heterozygous for the c.738G>A (p.Trp228stop) variant, while her mother and nephew were heterozygous for the c.938G>T (p.Ser295Ile). Both PolyPhen-2 and SIFT predicted that the p.Ser295Ile variant is likely to be deleterious and can affect the protein function. Modeling analysis indicated that the p.Ser295Ile variant may lead to disruption of a hydrogen bond, resulting in alteration of protein structure and instability.
CONCLUSION:The compound heterozygous c.738G>A (p.Trp228stop) and c.938G>T (p.Ser295Ile) variants of the F11 gene probably underlie the decreased FXI level in this pedigree.
